Literature DB >> 24461545

Effect of diabetes on treatment outcome of smear-positive pulmonary tuberculosis--a report from South India.

Vijay Viswanathan1, A Vigneswari2, K Selvan2, K Satyavani2, R Rajeswari2, Anil Kapur2.   

Abstract

AIM: To assess the effect of diabetes on tuberculosis (TB) treatment outcome and sputum conversion among new smear-positive (NSP) cases registered under Directly Observed Treatment Short Course in South India.
METHODS: Details on sputum conversion and TB treatment outcome were collected from case records of NSP cases (N = 332; M/F 247:85) registered at TB units of three districts in Tamil Nadu. Subjects were screened for diabetes and categorized as diabetic (TBDM) (n = 96; 73:23) and non-diabetic (TBnonDM) (n = 149; 109:40).
RESULTS: Among 245 selected TB patients, 93.5% were cured, 1.6% completed TB treatment, 2% had TB treatment failure (TF), and 0.4% had treatment default (TD), 0.4% with MDR-TB and 2% death rate. At the end of intensive phase of TB treatment, 14.7% remained sputum positive in the TBDM group, whereas it was 3.5% in the TBnonDM group. Mean duration (days) for sputum conversion was higher in the TBDM group (64.2 ± 10.5) compared to the TBnonDM group (61.5 ± 7.5) (p<0.001). TF rate was higher (4.2% vs 0.7%) and MDR-TB (1%) was also seen in the TBDM group. No death and TD were seen among DM whereas it was 3.4 and 0.7% in TBnonDM.
CONCLUSIONS: Delayed sputum conversion and high TB treatment failure rates were common in NSP cases with diabetes.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetes; South India; Treatment outcome; Tuberculosis

Mesh:

Year:  2013        PMID: 24461545     DOI: 10.1016/j.jdiacomp.2013.12.003

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  24 in total

1.  Diabetes screen during tuberculosis contact investigations highlights opportunity for new diabetes diagnosis and reveals metabolic differences between ethnic groups.

Authors:  Blanca I Restrepo; Léanie Kleynhans; Alejandra B Salinas; Bassent Abdelbary; Happy Tshivhula; Genesis P Aguillón-Durán; Carine Kunsevi-Kilola; Gloria Salinas; Kim Stanley; Stephanus T Malherbe; Elizna Maasdorp; Moncerrato Garcia-Viveros; Ilze Louw; Esperanza M Garcia-Oropesa; Juan Carlos Lopez-Alvarenga; John B Prins; Gerhard Walzl; Larry S Schlesinger; Katharina Ronacher
Journal:  Tuberculosis (Edinb)       Date:  2018-08-18       Impact factor: 3.131

Review 2.  Diabetes and Tuberculosis.

Authors:  Blanca I Restrepo
Journal:  Microbiol Spectr       Date:  2016-12

3.  CureTB and continuity of care for globally mobile patients.

Authors:  A Figueroa; L Vonnahme; K Burrell; C Vera-García; R K Gulati
Journal:  Int J Tuberc Lung Dis       Date:  2020-07-01       Impact factor: 2.373

4.  Prevalence and Impact of Diabetes Mellitus Among Patients with Active Pulmonary Tuberculosis in South Korea.

Authors:  Eun Hye Lee; Jung Mo Lee; Young Ae Kang; Ah Young Leem; Eun Young Kim; Ji Ye Jung; Moo Suk Park; Young Sam Kim; Se Kyu Kim; Joon Chang; Song Yee Kim
Journal:  Lung       Date:  2017-02-09       Impact factor: 2.584

Review 5.  Diabetes mellitus and its complications in India.

Authors:  Ranjit Unnikrishnan; Ranjit Mohan Anjana; Viswanathan Mohan
Journal:  Nat Rev Endocrinol       Date:  2016-04-15       Impact factor: 43.330

6.  Diabetes: A Contributor to Tuberculosis in Tropical Australia.

Authors:  Tahnee Bridson; Anthony Matthiesson; Leigh Owens; Brenda Govan; Robert Norton; Natkunam Ketheesan
Journal:  Am J Trop Med Hyg       Date:  2015-06-08       Impact factor: 2.345

7.  Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis Treatment.

Authors:  Omamah Alfarisi; Vidya Mave; Sanjay Gaikwad; Tushar Sahasrabudhe; Geetha Ramachandran; Hemanth Kumar; Nikhil Gupte; Vandana Kulkarni; Sona Deshmukh; Sachin Atre; Swapnil Raskar; Rahul Lokhande; Madhusudan Barthwal; Arjun Kakrani; Sandy Chon; Amita Gupta; Jonathan E Golub; Kelly E Dooley
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

8.  High Prevalence and Heterogeneity of Diabetes in Patients With TB in South India: A Report from the Effects of Diabetes on Tuberculosis Severity (EDOTS) Study.

Authors:  Hardy Kornfeld; Kim West; Kevin Kane; Satyavani Kumpatla; Rajesh Roy Zacharias; Carlos Martinez-Balzano; Wenjun Li; Vijay Viswanathan
Journal:  Chest       Date:  2016-03-10       Impact factor: 9.410

9.  Anti-tuberculosis drug concentrations in tuberculosis patients with and without diabetes mellitus.

Authors:  A K Hemanth Kumar; V Chandrasekaran; T Kannan; A Lakshmi Murali; J Lavanya; V Sudha; Soumya Swaminathan; Geetha Ramachandran
Journal:  Eur J Clin Pharmacol       Date:  2016-09-20       Impact factor: 2.953

Review 10.  Impact of diabetes on the natural history of tuberculosis.

Authors:  Blanca I Restrepo; Larry S Schlesinger
Journal:  Diabetes Res Clin Pract       Date:  2014-07-14       Impact factor: 5.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.